We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$678M
AUM Growth
-$129M
Cap. Flow
-$178M
Cap. Flow %
-26.18%
Top 10 Hldgs %
21.1%
Holding
174
New
44
Increased
23
Reduced
49
Closed
45

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$10.6M
2
RPD icon
Rapid7
RPD
+$9.7M
3
PZZA icon
Papa John's
PZZA
+$9.57M
4
BLD
TopBuild
BLD
+$8.63M
5
PYCR
Paycor HCM, Inc. Common Stock
PYCR
+$7.99M

Top Sells

Rank Stock Value
1
ASAN icon
Asana
ASAN
+$17.4M
2
CDNA icon
CareDx
CDNA
+$14.9M
3
SGRY icon
Surgery Partners
SGRY
+$11.8M
4
AZTA icon
Azenta
AZTA
+$11.5M
5
SITM icon
SiTime
SITM
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 31.4%
2 Healthcare 21.09%
3 Industrials 17.66%
4 Consumer Discretionary 15.18%
5 Financials 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FFIN icon
126
First Financial Bankshares
FFIN
$4.96B
$1.08M 0.16%
23,440
-16,650
-42% -$789K
TKNO icon
127
Alpha Teknova
TKNO
$344M
$944K 0.14%
37,910
-23,855
-39% -$511K
STLD icon
128
Steel Dynamics
STLD
$37.5B
$828K 0.12%
+14,160
New +$905K
ONON icon
129
On Holding
ONON
$12.6B
$608K 0.09%
+20,190
New +$709K
ACLS icon
130
Axcelis
ACLS
$4.28B
– –
-128,301
Closed -$5.19M
AEO icon
131
American Eagle Outfitters
AEO
$2.99B
– –
-117,690
Closed -$4.42M
ANF icon
132
Abercrombie & Fitch
ANF
$4.96B
– –
-78,230
Closed -$3.63M
APLS
133
DELISTED
Apellis Pharmaceuticals
APLS
– –
-119,445
Closed -$7.55M
APPN icon
134
Appian
APPN
$2.55B
– –
-42,355
Closed -$5.83M
ARWR icon
135
Arrowhead Research
ARWR
$12.3B
– –
-81,770
Closed -$6.77M
AZTA icon
136
Azenta
AZTA
$1.45B
– –
-120,385
Closed -$11.5M
BLDR icon
137
Builders FirstSource
BLDR
$8B
– –
-75,200
Closed -$3.21M
BLMN icon
138
Bloomin' Brands
BLMN
$939M
– –
-280,655
Closed -$7.62M
CAKE icon
139
Cheesecake Factory
CAKE
$5.31B
– –
-35,855
Closed -$1.94M
CDLX icon
140
Cardlytics
CDLX
$21.2M
– –
-2,643
Closed -$3.35M
CDNA icon
141
CareDx
CDNA
$2.37B
– –
-163,255
Closed -$14.9M
DNLI icon
142
Denali Therapeutics
DNLI
$3.9B
– –
-98,130
Closed -$7.7M
DOMO icon
143
Domo
DOMO
$183M
– –
-38,655
Closed -$3.12M
EEFT icon
144
Euronet Worldwide
EEFT
$2.67B
– –
-13,115
Closed -$1.77M
FATE icon
145
Fate Therapeutics
FATE
$297M
– –
-125,350
Closed -$10.9M
FIGS icon
146
FIGS
FIGS
$2.41B
– –
-132,725
Closed -$6.65M
FIVN icon
147
FIVE9
FIVN
$2.54B
– –
-16,110
Closed -$2.95M
FOUR icon
148
Shift4
FOUR
$3.21B
– –
-30,470
Closed -$2.86M
FRPT icon
149
Freshpet
FRPT
$3.23B
– –
-47,669
Closed -$7.77M
GRWG icon
150
GrowGeneration
GRWG
$90.7M
– –
-141,875
Closed -$6.82M
3 4 5
6
7

Similar funds

PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return

Lisanti Capital Growth's Q3 2021 Portfolio in Review

As of Q3 2021, Lisanti Capital Growth held 174 positions worth $678M, down 16% from $808M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lisanti Capital Growth withdrew a net $178M in Q3 2021, closing 45 positions and reducing 49 holdings. Its most notable exit was CareDx, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Biohaven Pharmaceutical Holding Company Ltd. worth $11.8M.

  • Lisanti Capital Growth's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 85,280 shares worth $11.8M.
  • Lisanti Capital Growth added most to Allegiant Air in Q3 2021, an estimated $3.11M increase.
  • Lisanti Capital Growth's biggest Q3 2021 reduction was Asana, cutting an estimated $17.4M.
  • Lisanti Capital Growth fully exited CareDx in Q3 2021, selling an estimated $14.9M.
  • Lisanti Capital Growth's ten largest holdings make up 21% of its $678M portfolio in Q3 2021.
  • Lisanti Capital Growth opened 44 new positions and closed 45 in Q3 2021.
  • Lisanti Capital Growth's portfolio value fell 16% quarter-over-quarter to $678M.

Based on Lisanti Capital Growth's 13F filing for Q3 2021, filed 3 Nov 2021.